Cite
HARVARD Citation
Ronda, M. et al. (2022). Ceftolozane/tazobactam for difficult‐to‐treat Gram‐negative infections: A real‐world tertiary hospital experience. Journal of clinical pharmacy and therapeutics. pp. 932-939. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Ronda, M. et al. (2022). Ceftolozane/tazobactam for difficult‐to‐treat Gram‐negative infections: A real‐world tertiary hospital experience. Journal of clinical pharmacy and therapeutics. pp. 932-939. [Online].